These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16804535)

  • 1. CIMPle origin for promoter hypermethylation in colorectal cancer?
    Schuebel K; Chen W; Baylin SB
    Nat Genet; 2006 Jul; 38(7):738-40. PubMed ID: 16804535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
    Matsubara N
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer: a model for epigenetic tumorigenesis.
    Wong JJ; Hawkins NJ; Ward RL
    Gut; 2007 Jan; 56(1):140-8. PubMed ID: 16840508
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting aberrant chromatin structure in colorectal carcinomas.
    Konishi K; Issa JP
    Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways to silencing unite.
    Hayes S
    Nat Cell Biol; 2006 Apr; 8(4):315. PubMed ID: 16607271
    [No Abstract]   [Full Text] [Related]  

  • 10. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MGMT hypermethylation: a prognostic foe, a predictive friend.
    Jacinto FV; Esteller M
    DNA Repair (Amst); 2007 Aug; 6(8):1155-60. PubMed ID: 17482895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic changes in cancer and preneoplasia.
    Herman JG
    Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation: the nuts and bolts of repression.
    Miranda TB; Jones PA
    J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation, field effects, and colorectal cancer.
    Giovannucci E; Ogino S
    J Natl Cancer Inst; 2005 Sep; 97(18):1317-9. PubMed ID: 16174847
    [No Abstract]   [Full Text] [Related]  

  • 18. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
    Choi JH; Park SH; Park J; Park BG; Cha SJ; Kong KH; Lee KH; Park AJ
    Biochem Biophys Res Commun; 2007 Sep; 361(3):615-20. PubMed ID: 17673177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene silencing by DNA methylation in haematological malignancies.
    Boultwood J; Wainscoat JS
    Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
    Lee J; Yoon YS; Chung JH
    Gynecol Oncol; 2008 May; 109(2):270-4. PubMed ID: 18377964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.